Kanokphong Suparan

ORCID: 0000-0002-6853-7387
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Gut microbiota and health
  • Alcohol Consumption and Health Effects
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Diet and metabolism studies
  • Colorectal Cancer Screening and Detection
  • Gastric Cancer Management and Outcomes
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer-related cognitive impairment studies
  • Diet, Metabolism, and Disease
  • Substance Abuse Treatment and Outcomes
  • Cancer, Lipids, and Metabolism
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Tryptophan and brain disorders
  • Gallbladder and Bile Duct Disorders
  • Cardiac Health and Mental Health
  • Pharmacological Effects and Toxicity Studies
  • Menopause: Health Impacts and Treatments
  • Digital Transformation in Industry
  • Regulation of Appetite and Obesity
  • Circadian rhythm and melatonin
  • Congenital gastrointestinal and neural anomalies
  • Biochemical effects in animals

Chiang Mai University
2019-2025

<h2>Abstract</h2><h3>Background & Aims</h3> Alcohol-associated liver diseases (ALDs) and alcohol use disorder (AUD) pose a global health risk. AUD is underrecognized in the elderly, burden of complications, including ALD, may increase with aging populations rising intake. However, there lack epidemiological evidence on ALD elderly. <h3>Methods</h3> Using Global Burden Disease Study 2019, we analyzed prevalence, mortality, disability-adjusted life years (DALYs), age-standardized rates (ASRs),...

10.1016/j.jhepr.2024.101020 article EN cc-by-nc-nd JHEP Reports 2024-01-26

Alcohol represents a leading burden of disease worldwide, including alcohol use disorder (AUD) and alcohol-related liver (ALD). We aim to assess the global AUD, ALD, alcohol-attributable primary cancer between 2000-2021. registered regional trends using data from Global Burden Disease 2021 Study, largest most up-to-date epidemiology database. estimated annual percent change (APC) its 95% confidence interval (CI) changes in age-standardized rates over time. In 2021, there were 111.12 million...

10.3350/cmh.2024.0835 article EN cc-by-nc Clinical and Molecular Hepatology 2025-01-09

Background: The incidence of cancer and the prevalence metabolic disease dysfunction–associated steatotic liver is increasing in young adults. However, updated global data on steatohepatitis (MASH)-associated primary (PLC) adults remains scarce. Methods: This study analyzed from Global Burden Disease between 2000 2021 to assess age-standardized incidence, mortality, disability-adjusted life years rates MASH-associated PLC (15–49 y). Results: In 2021, there were 4300 cases, 3550 deaths,...

10.1097/hc9.0000000000000629 article EN cc-by-nc-nd Hepatology Communications 2025-01-01

INTRODUCTION: The burden of alcohol-related complications is considerable, particularly alcohol-associated liver disease and alcohol use disorder (AUD). However, there are deficiencies in comprehensive epidemiological research focusing on these issues, especially among young women who display higher susceptibility to such compared with their male counterparts. We thus aimed determine the global conditions this vulnerable group. METHODS: Leveraging data from Global Burden Disease Study 2019,...

10.14309/ajg.0000000000002642 article EN The American Journal of Gastroenterology 2023-12-26

Objectives Despite evidence of increased incidence early-onset pancreatic cancer (EOPC), defined as diagnosed in patients below 50 years old, and its risk factors the Western region, global epidemiological data addressing this issue is still lacking. Materials Methods Utilizing from Global Burden Disease Study 2019, we aimed to conduct a comprehensive analysis incidence, deaths, disability-adjusted life (DALYs) associated with EOPC factors, including smoking, obesity, diabetes. The examined...

10.1097/mpa.0000000000002331 article EN Pancreas 2024-03-13

Abstract Background and Aim In recent years, there has been a growing incidence of gastrointestinal cancer in young individuals. Despite its significant morbidity mortality, research on upper (UGI) populations relatively limited. Therefore, studies the epidemiological changes this are needed. Methods Using data from Global Burden Disease Study 2019, we examined incidence, death, disability‐adjusted life years (DALYs) UGI cancers young, namely, early‐onset esophageal (EOEC) gastric (EOGC)....

10.1111/jgh.16620 article EN Journal of Gastroenterology and Hepatology 2024-05-21

Inflammatory bowel disease (IBD), once thought to impact younger individuals, now manifests in approximately 10% of patients over 65, characterized by a heightened vulnerability complications and greater diagnostic intricacies than conventional cases. However, comprehensive global epidemiological data regarding elderly-onset IBD are currently insufficient. Our study addresses this critical gap analyzing trends decade, encompassing the estimation annual frequencies age-standardized rates...

10.3390/jcm12155142 article EN Journal of Clinical Medicine 2023-08-06

Background/Objectives: The incidence and mortality of early-onset cancers have been rising in recent decades. While epidemiological studies examined various types cancer, updated global data on alcohol-attributable primary liver cancer (PLC) young adults remains limited. Methods: This study utilized from the Global Burden Disease (GBD) spanning 2000 to 2021 evaluate age-standardized incidence, mortality, corresponding rates PLC among aged 15–49 years. Results: In 2021, there were 8290 cases...

10.3390/cancers17040609 article EN Cancers 2025-02-11

Abstract Background and Aim The global burden of gallbladder biliary tract cancer (GBTC) has been on the rise, making it a major public health concern. We aim to comprehensively analyze sex disparities in temporal trends GBTC incidence, mortality, disability‐adjusted life years (DALYs) regionally globally from 2010 2019. Methods Age‐standardized rates death, DALYs were analyzed utilizing Global Burden Disease study Results From 2019, estimated annual percent change (APC) age‐standardized...

10.1111/jgh.16763 article EN Journal of Gastroenterology and Hepatology 2024-10-08

Iron overload causes cognitive impairment in thalassemia patients. The gut-brain axis plays an important role function. However, the association between gut/blood microbiome, cognition, and iron burden patients has not been thoroughly investigated. We aimed to determine those associations with different blood-transfusion regimens. Sixty participants: healthy controls, transfusion-dependent (TDT) patients, non-transfusion-dependent (NTDT) were recruited evaluate overload, microbiome. TDT...

10.1038/s41598-024-76684-4 article EN cc-by-nc-nd Scientific Reports 2024-10-23

Constipation is one of the most common gastrointestinal complaints in United States, and multiple interventions behavioral changes are often required to alleviate it. Vegetables diet recommendations for constipated patients, but amount constipation impact still limited.

10.1080/08998280.2024.2375903 article EN Baylor University Medical Center Proceedings 2024-07-16

Pancreatic cancer is a neoplastic condition with high disease burden. It projected to be the second most common cause of cancer-related deaths by 2030. However, evidence supporting long-term use aspirin in prevention and treatment remains insufficient. We aimed investigate association between pancreatic outcomes elderly population group. The 2020 National Inpatient Sample was used records patients admitted cancer, identified ICD-10 CM codes. data were categorized based on use. assessed...

10.20524/aog.2024.09179 article EN PubMed 2024-11-21

4104 Background: Gut microbiota established crucial roles in host metabolism and several diseases, particularly cancers. Distinct bacterial profiles from intestine are found to be a potential factor carcinogenesis, while some of those associated with detrimental treatment the responsiveness various types cancer. Association gut outcome has been thoroughly investigated intrahepatic cholangiocarcinoma (ICCA). The present study aimed compare between chemotherapy responder non-responder ICCA...

10.1200/jco.2023.41.16_suppl.4104 article EN Journal of Clinical Oncology 2023-06-01
Coming Soon ...